Design and synthesis of gene-targeting compounds as new and novel anticancer agents, Multi-disciplinary research programmes including organic synthesis, and their targeted delivery as prodrugs, combinatorial and green chemistry including chemical biology and biocatalysis, medicinal
Birla Institute of Technology & Science, Pilani Hyderabad Campus Jawahar Nagar, Kapra Mandal Dist.-Medchal-500 078 Telangana, India
Five (5) of the US patents have been licensed to a pharmaceutical company for their clinical development at an upfront payment of Rs. 5 million and milestone payments of about Rs. 24 million apart from royalties. Some of the compounds from these patents have been completed preclinical studies, and are likely to taken up for clinical studies.